首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1829767

2025年全球病人自控注射器市場報告

Patient Controlled Injectors Global Market Report 2025

出版日期: 2025年09月11日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，患者自控注射器市場快速擴張，市場規模從2024年的45.1億美元成長至2025年的50.8億美元，複合年成長率達12.5%。預測期內的成長歸因於居家醫療的成長、醫療基礎設施的擴展、糖尿病患者數量的增加、感染疾病病率的上升以及對個性化醫療的日益關注。

預計未來幾年患者自控注射器市場將快速成長，到2029年將達到79.4億美元，複合年成長率為11.8%。預測期內的成長歸因於人口老化加劇、慢性呼吸系統疾病盛行率上升、慢性病盛行率上升、癌症盛行率上升以及自體免疫疾病盛行率上升。預測期內的主要趨勢包括技術進步、人工智慧整合、遠端醫療、遠端監控、攜帶式和穿戴式設備的進步以及對微創手術的重視。

患者控制注射器是醫療設備，旨在讓患者自行給藥，精確控制劑量和時間，易於使用，並允許患者獨立管理治療，通常在家中。

患者控制注射器的主要類型包括電子穿戴式注射器、機械穿戴式注射器和輸液幫浦。電子注射器能夠實現自動化和精準的藥物輸送，並且通常具備追蹤和監控使用情況的連接功能，從而為患者提供更高的便利性和數據主導的洞察。這些設備用於治療癌症、自體免疫疾病和血液疾病等疾病，並透過醫院藥局、零售藥局和通訊銷售管道銷售。

2025年春季美國大幅提高關稅及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供病人自控注射器市場統計數據，例如全球市場規模、區域佔有率、病人自控注射器市場佔有率的競爭對手、詳細的病人自控注射器市場細分、市場趨勢以及病人自控注射器行業的商機，為您提供在病人自控注射器行業取得成功所需的數據。本病人自控注射器研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全面觀點。

我們預測未來五年該市場將成長11.8%，較先前預測略有下降0.9%。下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，導致精密微流體幫浦和拋棄式墨盒的供應延遲，這些產品嚴重依賴從愛爾蘭和台灣進口，從而擾亂疼痛管理療法。由於互惠關稅以及不斷升級的貿易緊張局勢和限制對全球經濟和貿易造成的負面影響，這種影響也將更加廣泛。

預計未來幾年慢性病盛行率的上升將推動患者控制注射器市場的成長。人口老化、肥胖症流行、社會經濟經濟狀況和環境因素等因素正在推動持續時間超過三個月且往往會隨著時間的推移而惡化的慢性病的增加。患者控制注射器使患者能夠根據治療計劃準確、方便地自行服藥。例如，2023 年 1 月，美國國家生物技術資訊中心 (NCBI) 預測，患有一種或多種慢性病的 50 歲及以上人數將從 2020 年的 7152 萬人增加 99.5% 到 2050 年的 1.4266 億。因此，預計慢性病盛行率的上升將推動患者控制注射器市場向前發展。

為了更好地滿足客戶需求，該市場的主要企業正在透過開發即用型注射器等先進產品進行創新。即用型注射器預先填充並滅菌，並配備精確劑量的藥物，無需手動準備，並降低了污染和給藥錯誤的風險。例如，Ypsomed AG 於 2022 年 10 月推出了專為 1.5 至 5.5 毫升液體藥物設計的新型自動注射器平台。本設備採用符合人體工學的使用者友善設計，確保患者在注射過程中的舒適度，並配備先進的安全機制，防止針刺傷。此外，視覺和聽覺回饋可確認藥物傳遞是否成功，且其與各種黏度藥物的兼容性使其適用於各種治療應用。

2023年4月，LTS Lohmann Therapie-Systeme AG 收購了 Eitan Medical 旗下的 Sorrel 穿戴式注射器業務，擴大了其藥物輸送產品組合。此次收購增強了 LTS 在先進穿戴式注射技術領域的能力，並進一步鞏固了該公司在患者控制注射器市場的地位。 Eitan Medical Ltd. 是一家總部位於以色列的公司，致力於開發創新藥物輸送設備，包括病患控制注射器。

患者自控注射器市場包括預填充式注射器、自動注射器、內建注射器和無針注射器的銷售。該市場的價值是指“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

全球病患自控注射器：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
最終用途產業分析
全球病患自控注射器市場：成長率分析
全球病患自控注射器市場表現：規模與成長，2019-2024
全球病患自控注射器市場預測：規模與成長，2024-2029年，2034年
全球病患自控注射器：總目標市場（TAM）

第6章市場細分

全球病患自控注射器市場：依產品、實際及預測，2019-2024 年、2024-2029 年、2034 年
電子穿戴式注射器
機械式穿戴式注射器
點滴幫浦
全球病患自控注射器市場：依應用、實際及預測，2019-2024 年、2024-2029 年、2034 年
癌症治療
自體免疫治療
血液疾病的治療
其他應用
全球病患自控注射器市場：依通路、實際及預測，2019-2024 年、2024-2029 年、2034 年
醫院藥房
零售藥局
通訊藥房
全球病患控制注射器市場：按類型細分：穿戴式電子注射器，實際及預測，2019-2024 年、2024-2029 年、2034 年
預填充電子穿戴式注射器
可程式設計電子穿戴式注射器
智慧電子穿戴式注射器
充電式穿戴式電子注射器
支援藍牙的穿戴式電子注射器
免洗電子穿戴式注射器
全球病患控制注射器市場：依機械穿戴式注射器類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
彈簧式機械穿戴式注射器
穿戴式活塞式機械注射器
自動注射器（機械）
手動機械穿戴式注射器
免洗式穿戴式機械注射器
全球病患控制注射器市場：依輸液幫浦類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
一次性輸液泵
可程式設計輸液泵
胰島素輸注泵
注射輸液幫浦
攜帶式輸液泵
大容量輸液泵
植入式輸液泵

第7章區域和國家分析

全球病患自控注射器市場：按地區、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
全球病人自控注射器市場：國家、現況及預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章：澳洲市場

第13章印尼市場

第14章韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

病患控制注射器市場：競爭格局
病患控制注射器市場：公司簡介
- Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- West Pharmaceutical Services Overview, Products and Services, Strategy and Financial Analysis
- SCHOTT AG Overview, Products and Services, Strategy and Financial Analysis
- Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

Phillips-Medisize
Vetter Pharma-Fertigung GmbH & Co. KG
Stevanato Group
Ypsomed AG
Nemera
B. Braun Melsungen AG
Elcam Medical
Owen Mumford
Bespak
Unilife Corporation
Crossject
SHL Group
AptarGroup Inc.
Credence MedSystems
Weibel CDS AG

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

2029年病患自控注射器市場：提供新機會的國家
2029年病患自控注射器市場：細分市場帶來新機會
2029年病患自控注射器市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第36章附錄

簡介目錄

Product Code: r30899u

Patient-controlled injectors are medical devices designed to empower patients to self-administer medication with precise control over dosage and timing. They are user-friendly, facilitating independent management of treatment, typically in home settings.

The primary types of patient-controlled injectors include electronic wearable injectors, mechanical wearable injectors, and infusion pumps. Electronic versions enable automated and precise medication delivery, often equipped with connectivity features for tracking and monitoring usage. This enhances convenience and provides data-driven insights for patients. These devices find applications in treatments such as cancer, autoimmune disorders, and blood disorders, distributed through hospital pharmacies, retail pharmacies, and mail-order channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The patient-controlled injectors market research report is one of a series of new reports from The Business Research Company that provides patient-controlled injectors market statistics, including patient-controlled injectors industry global market size, regional shares, competitors with a patient-controlled injectors market share, detailed patient-controlled injectors market segments, market trends, and opportunities, and any further data you may need to thrive in the patient-controlled injectors industry. This patient-controlled injectors research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The patient controlled injectors market size has grown rapidly in recent years. It will grow from $4.51 billion in 2024 to $5.08 billion in 2025 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to growth in home healthcare, expansion of healthcare infrastructure, increasing cases of diabetes, increased prevalence of infectious diseases, and increasing focus on personalized medicine.

The patient controlled injectors market size is expected to see rapid growth in the next few years. It will grow to $7.94 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to a rising aging population, rising incidence of chronic respiratory diseases, increasing prevalence of chronic diseases, increasing cancer cases, and increasing autoimmune disorders prevalence. Major trends in the forecast period include technological advancements, integration of artificial intelligence, telemedicine, remote monitoring, advancements in portable and wearable devices, and focus on minimally invasive procedures.

The forecast of 11.8% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply delays for precision microfluidic pumps and disposable cartridges, heavily reliant on imports from Ireland and Taiwan, disrupting pain management therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is poised to drive the growth of the patient-controlled injectors market in the coming years. Chronic illnesses, lasting three months or more and often worsening over time, are increasing due to factors such as an aging population, the obesity epidemic, socioeconomic conditions, and environmental factors. Patient-controlled injectors enable individuals to self-administer medications accurately, conveniently, and according to their treatment schedules. For example, the National Center for Biotechnology Information (NCBI) projected in January 2023 that the number of individuals aged 50 and older with one or more chronic conditions will rise by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Therefore, the growing prevalence of chronic diseases is expected to propel the patient-controlled injectors market forward.

Leading companies in this market are innovating by developing advanced products such as ready-to-use syringes to better meet customer needs. Ready-to-use syringes come prefilled and sterilized with a precise dose of medication, eliminating the need for manual preparation and reducing risks of contamination and dosing errors. For instance, in October 2022, Ypsomed AG introduced a new autoinjector platform tailored for liquid pharmaceuticals ranging from 1.5 to 5.5 ml. This device features ergonomic design for ease of use, ensuring patient comfort during injections, along with advanced safety mechanisms to prevent accidental needle sticks. It provides visual and audible feedback to confirm successful medication delivery and is versatile for various therapeutic applications due to its compatibility with different viscosities.

In April 2023, LTS Lohmann Therapie-Systeme AG expanded its drug delivery portfolio by acquiring the sorrel wearable injection device business from Eitan Medical. This acquisition enhances LTS's capabilities in advanced wearable injection technologies, further solidifying its presence in the patient-controlled injectors market. Eitan Medical Ltd. is an Israel-based company that develops innovative drug delivery devices, including patient-controlled injectors.

Major companies operating in the patient controlled injectors market are Medtronic plc, Becton Dickinson and Company, West Pharmaceutical Services, SCHOTT AG, Gerresheimer AG, Phillips-Medisize, Vetter Pharma-Fertigung GmbH & Co. KG, Stevanato Group, Ypsomed AG, Nemera, B. Braun Melsungen AG, Elcam Medical, Owen Mumford, Bespak, Unilife Corporation, Crossject, SHL Group, AptarGroup Inc., Credence MedSystems, Weibel CDS AG, Sorrel Medical

North America was the largest region in the patient controlled injectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient controlled injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the patient controlled injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The patient-controlled injectors market consists of sales of prefilled syringes, auto-injectors, on-body injectors, and needle-free injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Patient Controlled Injectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on patient controlled injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for patient controlled injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The patient controlled injectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Electronic Wearable Injector; Mechanical Wearable Injector; Infusion Pumps
2) By Application: Cancer Treatment; Auto-Immune Treatment; Blood Disorder Treatment; Other Application
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail Order Pharmacies
Subsegments:
1) By Electronic Wearable Injector: Pre-Filled Electronic Wearable Injectors; Programmable Electronic Wearable Injectors; Smart Electronic Wearable Injectors; Rechargeable Electronic Wearable Injectors; Bluetooth-Enabled Electronic Wearable Injectors; Disposable Electronic Wearable Injectors
2) By Mechanical Wearable Injector: Spring-Loaded Mechanical Wearable Injectors; Piston-Based Mechanical Wearable Injectors; Auto-Injectors (Mechanical); Manual Mechanical Wearable Injectors; Disposable Mechanical Wearable Injectors
3) By Infusion Pumps: Disposable Infusion Pumps; Programmable Infusion Pumps; Insulin Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps; Large Volume Infusion Pumps; Implantable Infusion Pumps
Companies Mentioned: Medtronic plc; Becton Dickinson and Company; West Pharmaceutical Services; SCHOTT AG; Gerresheimer AG; Phillips-Medisize; Vetter Pharma-Fertigung GmbH & Co. KG; Stevanato Group; Ypsomed AG; Nemera; B. Braun Melsungen AG; Elcam Medical; Owen Mumford; Bespak; Unilife Corporation; Crossject; SHL Group; AptarGroup Inc.; Credence MedSystems; Weibel CDS AG; Sorrel Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Patient Controlled Injectors Market Characteristics

3. Patient Controlled Injectors Market Trends And Strategies

4. Patient Controlled Injectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Patient Controlled Injectors Growth Analysis And Strategic Analysis Framework

5.1. Global Patient Controlled Injectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Patient Controlled Injectors Market Growth Rate Analysis
5.4. Global Patient Controlled Injectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Patient Controlled Injectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Patient Controlled Injectors Total Addressable Market (TAM)

6. Patient Controlled Injectors Market Segmentation

6.1. Global Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electronic Wearable Injector
Mechanical Wearable Injector
Infusion Pumps
6.2. Global Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Treatment
Auto-Immune Treatment
Blood Disorder Treatment
Other Application
6.3. Global Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
6.4. Global Patient Controlled Injectors Market, Sub-Segmentation Of Electronic Wearable Injector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pre-Filled Electronic Wearable Injectors
Programmable Electronic Wearable Injectors
Smart Electronic Wearable Injectors
Rechargeable Electronic Wearable Injectors
Bluetooth-Enabled Electronic Wearable Injectors
Disposable Electronic Wearable Injectors
6.5. Global Patient Controlled Injectors Market, Sub-Segmentation Of Mechanical Wearable Injector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Spring-Loaded Mechanical Wearable Injectors
Piston-Based Mechanical Wearable Injectors
Auto-Injectors (Mechanical)
Manual Mechanical Wearable Injectors
Disposable Mechanical Wearable Injectors
6.6. Global Patient Controlled Injectors Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disposable Infusion Pumps
Programmable Infusion Pumps
Insulin Infusion Pumps
Syringe Infusion Pumps
Ambulatory Infusion Pumps
Large Volume Infusion Pumps
Implantable Infusion Pumps

7. Patient Controlled Injectors Market Regional And Country Analysis

7.1. Global Patient Controlled Injectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Patient Controlled Injectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Patient Controlled Injectors Market

8.1. Asia-Pacific Patient Controlled Injectors Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Patient Controlled Injectors Market

9.1. China Patient Controlled Injectors Market Overview
9.2. China Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Patient Controlled Injectors Market

10.1. India Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Patient Controlled Injectors Market

11.1. Japan Patient Controlled Injectors Market Overview
11.2. Japan Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Patient Controlled Injectors Market

12.1. Australia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Patient Controlled Injectors Market

13.1. Indonesia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Patient Controlled Injectors Market

14.1. South Korea Patient Controlled Injectors Market Overview
14.2. South Korea Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Patient Controlled Injectors Market

15.1. Western Europe Patient Controlled Injectors Market Overview
15.2. Western Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Patient Controlled Injectors Market

16.1. UK Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Patient Controlled Injectors Market

17.1. Germany Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Patient Controlled Injectors Market

18.1. France Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Patient Controlled Injectors Market

19.1. Italy Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Patient Controlled Injectors Market

20.1. Spain Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Patient Controlled Injectors Market

21.1. Eastern Europe Patient Controlled Injectors Market Overview
21.2. Eastern Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Patient Controlled Injectors Market

22.1. Russia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Patient Controlled Injectors Market

23.1. North America Patient Controlled Injectors Market Overview
23.2. North America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Patient Controlled Injectors Market

24.1. USA Patient Controlled Injectors Market Overview
24.2. USA Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Patient Controlled Injectors Market

25.1. Canada Patient Controlled Injectors Market Overview
25.2. Canada Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Patient Controlled Injectors Market

26.1. South America Patient Controlled Injectors Market Overview
26.2. South America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Patient Controlled Injectors Market

27.1. Brazil Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Patient Controlled Injectors Market

28.1. Middle East Patient Controlled Injectors Market Overview
28.2. Middle East Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Patient Controlled Injectors Market

29.1. Africa Patient Controlled Injectors Market Overview
29.2. Africa Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Patient Controlled Injectors Market Competitive Landscape And Company Profiles

30.1. Patient Controlled Injectors Market Competitive Landscape
30.2. Patient Controlled Injectors Market Company Profiles
- 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. West Pharmaceutical Services Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. SCHOTT AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis

31. Patient Controlled Injectors Market Other Major And Innovative Companies

31.1. Phillips-Medisize
31.2. Vetter Pharma-Fertigung GmbH & Co. KG
31.3. Stevanato Group
31.4. Ypsomed AG
31.5. Nemera
31.6. B. Braun Melsungen AG
31.7. Elcam Medical
31.8. Owen Mumford
31.9. Bespak
31.10. Unilife Corporation
31.11. Crossject
31.12. SHL Group
31.13. AptarGroup Inc.
31.14. Credence MedSystems
31.15. Weibel CDS AG

32. Global Patient Controlled Injectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Patient Controlled Injectors Market

34. Recent Developments In The Patient Controlled Injectors Market

35. Patient Controlled Injectors Market High Potential Countries, Segments and Strategies

35.1 Patient Controlled Injectors Market In 2029 - Countries Offering Most New Opportunities
35.2 Patient Controlled Injectors Market In 2029 - Segments Offering Most New Opportunities
35.3 Patient Controlled Injectors Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies